LXRX Q3 2017 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M-2.8% YoY

Gross Profit

$26M97.8% margin

Operating Income

-$30M-109.6% margin

Net Income

-$31M-114.0% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+123.5%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$329M

Total Liabilities

$251M

Stockholders' Equity

$78M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$28M	-2.8%
Gross Profit	$26M	-$25M	+206.2%
Operating Income	-$30M	-$35M	+15.5%
Net Income	-$31M	-$36M	+14.7%